362 related articles for article (PubMed ID: 26075536)
41. Participation of endogenous opiates in regulation of the hypothalamic-pituitary-testicular axis in normal men.
Delitala G; Giusti M; Mazzocchi G; Granziera L; Tarditi W; Giordano G
J Clin Endocrinol Metab; 1983 Dec; 57(6):1277-81. PubMed ID: 6415088
[TBL] [Abstract][Full Text] [Related]
42. Obesity and testicular function.
Mah PM; Wittert GA
Mol Cell Endocrinol; 2010 Mar; 316(2):180-6. PubMed ID: 19540307
[TBL] [Abstract][Full Text] [Related]
43. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update.
Petak SM; Nankin HR; Spark RF; Swerdloff RS; Rodriguez-Rigau LJ;
Endocr Pract; 2002; 8(6):440-56. PubMed ID: 15260010
[TBL] [Abstract][Full Text] [Related]
44. Androgen replacement therapy in late-onset hypogonadism: current concepts and controversies - a mini-review.
Mäkinen JI; Huhtaniemi I
Gerontology; 2011; 57(3):193-202. PubMed ID: 20689266
[TBL] [Abstract][Full Text] [Related]
45. Pattern of Male Hypogonadism and Outcome of Treatment in South Rajasthan.
Sharma KR; Sharma H; Vishnoi J; Sharma RK; Goel S
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443335
[TBL] [Abstract][Full Text] [Related]
46. [Diagnosis and treatment of hypogonadism in adult males].
Köhn FM
Hautarzt; 2004 Sep; 55(9):877-895; quiz 896-7. PubMed ID: 15484339
[TBL] [Abstract][Full Text] [Related]
47. Changes in the hypothalamic-pituitary-gonadal axis in men after cadaver kidney transplantation and cyclosporine therapy.
Samojlik E; Kirschner MA; Ribot S; Szmal E
J Androl; 1992; 13(4):332-6. PubMed ID: 1399835
[TBL] [Abstract][Full Text] [Related]
48. Approach to the Patient: The Evaluation and Management of Men ≥50 Years With Low Serum Testosterone Concentration.
Grossmann M; Jayasena CN; Anawalt BD
J Clin Endocrinol Metab; 2023 Aug; 108(9):e871-e884. PubMed ID: 36995891
[TBL] [Abstract][Full Text] [Related]
49. Aging of the brain-testicular axis: reproductive systems of healthy old male rats with or without endocrine stimulation.
Taylor G; Bardgett M; Farr S; Humphrey W; Womack S; Weiss J
Proc Soc Exp Biol Med; 1996 Jan; 211(1):69-75. PubMed ID: 8594620
[TBL] [Abstract][Full Text] [Related]
50. [Testosterone deficit syndrome in the chronic renal failure patient].
Lledó García E; Jara Rascón J
Arch Esp Urol; 2013 Sep; 66(7):703-10. PubMed ID: 24047630
[TBL] [Abstract][Full Text] [Related]
51. Testosterone replacement therapy in male late onset hypogonadism: available pharmacological strategies.
Turchi P; Simi S; Pescatori ES
J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):61-8. PubMed ID: 16760628
[TBL] [Abstract][Full Text] [Related]
52. The aging male: androgens, erectile dysfunction, and depression.
Seidman SN
J Clin Psychiatry; 2003; 64 Suppl 10():31-7. PubMed ID: 12971814
[TBL] [Abstract][Full Text] [Related]
53. Late-Onset Hypogonadism and Testosterone Replacement in Older Men.
Bhattacharya RK; Bhattacharya SB
Clin Geriatr Med; 2015 Nov; 31(4):631-44. PubMed ID: 26476121
[TBL] [Abstract][Full Text] [Related]
54. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.
Lunenfeld B; Saad F; Hoesl CE
Aging Male; 2005 Jun; 8(2):59-74. PubMed ID: 16096160
[TBL] [Abstract][Full Text] [Related]
55. Effect of nitric oxide synthase inhibitors on preventing ethanol-induced suppression of the hypothalamic-pituitary-gonadal axis in the male rat.
Shi Q; Emanuele NV; Emanuele MA
Alcohol Clin Exp Res; 1998 Nov; 22(8):1763-70. PubMed ID: 9835292
[TBL] [Abstract][Full Text] [Related]
56. Testosterone replacement therapy: who to evaluate, what to use, how to follow, and who is at risk?
Afiadata A; Ellsworth P
Hosp Pract (1995); 2014 Dec; 42(5):69-82. PubMed ID: 25485919
[TBL] [Abstract][Full Text] [Related]
57. [Relevant clinical and biological criteria for the diagnosis of androgen deficiency in the aging male (ADAM)].
Seisen T; Rouprêt M; Gallais JL; Costa P
Prog Urol; 2012 Jun; 22 Suppl 1():S21-6. PubMed ID: 22770497
[TBL] [Abstract][Full Text] [Related]
58. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
[TBL] [Abstract][Full Text] [Related]
59. Androgen deficiency in aging men: role of testosterone replacement therapy.
Morley JE; Perry HM
J Lab Clin Med; 2000 May; 135(5):370-8. PubMed ID: 10811051
[No Abstract] [Full Text] [Related]
60. Declining testicular function in aging men.
Tenover JS
Int J Impot Res; 2003 Aug; 15 Suppl 4():S3-8. PubMed ID: 12934044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
